Medical writers for office of biostatistics and pharmacovigilance (obpv)
Ended Awarded Last action
- Contract number
- 75F40122F19003
- Awardee
-
Kaiva Strategies, LLC UEI HCWKVFGBPA64
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $542,674
Award facts
- Contract value 100% obligated
- $542,674.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- 8(a) Sole Source
- Competition
- Not Available for Competition Only One Source
- Pricing
- Labor Hours
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$17,516 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $560,190 |
About this award
The Food and Drug Administration issued a delivery order to Kaiva Strategies, LLC, a tribally-owned, minority-owned 8(a) small business, on July 1, 2022, with a ceiling value of $542,674.27 under an 8(a) sole source set-aside for medical writing support to the Office of Biostatistics and Pharmacovigilance.
Place of performance is Silver Spring, Maryland. The order's ultimate completion date is September 29, 2024. Work is priced on a labor-hours basis. Kaiva invoiced $206 thousand in FY2023 and $292 thousand in FY2024, with a labor footprint of 0.5 FTEs across 1,103 contractor hours in FY2024. The derived government-paid rate declined from $3,327.54 per hour in FY2023 to $264.96 per hour in FY2024, reflecting a shift in FY2024 toward subcontractor engagement at 100 percent of hours.
Quick answers
Who was awarded contract 75F40122F19003?
75F40122F19003 was awarded to Kaiva Strategies, LLC by Food and Drug Administration (Department of Health and Human Services) on July 1, 2022.
How much is contract 75F40122F19003 worth?
The government has obligated $542,674 on 75F40122F19003.
Is contract 75F40122F19003 an order under another contract?
Yes. 75F40122F19003 is a delivery order under 75F40122D00018, an indefinite delivery contract.
Was contract 75F40122F19003 competed?
The extent of competition for 75F40122F19003 was not available for competition. It was set aside: 8(a) Sole Source.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award